Latest news with #AIin
Malaysian Reserve
14-07-2025
- Business
- Malaysian Reserve
Wondershare Named a 2025 Top 20 AI Content Creation & Authoring Tools Company by Training Industry
VANCOUVER, BC, July 14, 2025 /PRNewswire/ — Wondershare Technology, a global leader in creative software solutions, is proud to announce that it has been recognized by Training Industry as one of the Top 20 AI Content Creation & Authoring Tools Companies for 2025. The recognition reflects the strength of Wondershare's overall strategy and capabilities in AI-driven content development. Among its submissions, EdrawMind, the company's advanced mind mapping and idea structuring software, stood out for its intuitive AI features that empower users to transform unstructured thoughts into clear, shareable visual outputs. The product offers a comprehensive AI toolkit, including AI Mindmap Generation, AI SWOT Analysis, AI Summary, AI Mindmap to Slide, AI Mindmap to Video, and AI Poster, enabling users to accelerate idea development and seamlessly convert their thinking into professional, multi-format deliverables. These capabilities make EdrawMind a valuable tool for learners, educators, and professionals who seek to streamline complex thinking and content creation processes. 'This award is a great testament to the work we're doing at Wondershare to push the boundaries of creativity and productivity through AI,' said Eric, Product Lead of EdrawMind, 'We're thrilled that EdrawMind was recognized as a standout product, and even more excited that this reflects positively on our broader mission to empower global users through smart, accessible technology.' While EdrawMind served as the highlight of this year's submission, Wondershare's recognition represents a broader ecosystem of AI-enhanced tools that support learning and content creation. These include EdrawMax, an all-in-one diagram maker, and Filmora, a video creativity software. Together, they reflect Wondershare's commitment to building intelligent, user-centered software that enhances how ideas are created, communicated, and shared. As AI continues to reshape the learning and development landscape, Training Industry introduced a new structure for its 2025 recognition, dividing the AI in Training award into two distinct categories for the first time: AI Coaching and Learner Support and AI Content Creation and Authoring Tools. This shift reflects a growing clarity in how AI is being applied to solve specific challenges—from in-the-flow learner support to intelligent content generation. Wondershare was recognized in the latter category, which represents one of the most dynamic and fast-growing areas in corporate training. About Wondershare: Wondershare is a globally recognized software company founded in 2003, known for its innovative solutions in creativity and productivity. Driven by the mission 'Creativity Simplified', Wondershare offers a range of tools, including Filmora, Virbo for video editing; PDFelement for document management; EdrawMax, EdrawMind for diagramming; and SelfyzAI, Pixpic for image recovery and editing. With over 1.5 billion users across 200+ countries and regions, Wondershare empowers the next generation of creators with intuitive software and trendy creative resources, continually expanding the possibilities of creativity worldwide.
Calgary Herald
22-05-2025
- Business
- Calgary Herald
'Nobody will wait for us': Tech sector says urgency is key for new AI minister Evan Solomon
Article content Canada's first-ever minister of artificial intelligence and digital innovation will need to accelerate the build-out of the country's AI infrastructure while cultivating trust in the technology in the general public — and many in the industry are warning there will be little room for trial and error along the way. Article content Last week, Prime Minister Mark Carney named former journalist Evan Solomon to the newly created post, which will have him oversee the country's adoption of the much-hyped technology. Carney has promised to run a lean and efficient government focused on growth and productivity, with technologies such as AI playing a crucial role in keeping Canada competitive and self-reliant. Article content 'We were one of the first countries to come out with an AI policy roadmap in 2017. (But Canada's leadership position) has slipped away in the last few years,' said Rob Goehring, executive director of industry group AI in B.C. and chief executive of cybersecurity firm WisrAI. Article content In 2021, Canada ranked fourth worldwide on the Global AI Index, a data project from U.K. digital media site Tortoise that tracks countries' AI capacity based on implementation, innovation and investment. By 2024, Canada had dropped to eighth place behind countries such as Germany, France and South Korea. Article content Carney has pledged to build on the Trudeau government's AI commitments, meaning existing commitments to channel $2.5 billion over the next two years to further AI and digital infrastructure projects, such as building data centres, expanding cloud computing capacity and procuring cutting-edge chips will likely be maintained. Article content Article content The full scope of what Solomon and the government will add to that strategy has yet to be revealed, but industry players say the need for urgency is essential. Article content Article content 'It's critical that we invest and move at a fast pace, because it's clear that nobody will wait for us,' said Julien Billot, CEO of Montreal-based Scale AI, a federally-backed supercluster that helps industry adopt AI technologies. Article content That means prioritizing the cultivation of AI talent and keeping it here, while helping researchers and businesses optimize existing resources to 'build smaller and more energy-efficient models … instead of trying to build from scratch.'
Yahoo
21-05-2025
- Business
- Yahoo
Global AI in Diagnostics Market to Register Stunning Growth at a CAGR of ~22% by 2032
The increasing incidence of infectious and chronic illnesses is boosting the need for early and precise diagnosis, with AI playing a crucial role by improving detection and enabling quicker clinical decisions. At the same time, the widespread adoption of digital health and imaging technologies creates a solid base for integrating AI into current healthcare systems, enhancing both efficiency and accuracy. Furthermore, ongoing product innovation by major global players, driven by progress in machine learning and growing regulatory backing, is accelerating the availability of AI-based diagnostic solutions. New York, USA, May 21, 2025 (GLOBE NEWSWIRE) -- Global AI in Diagnostics Market to Register Stunning Growth at a CAGR of ~22% by 2032 | DelveInsight The increasing incidence of infectious and chronic illnesses is boosting the need for early and precise diagnosis, with AI playing a crucial role by improving detection and enabling quicker clinical decisions. At the same time, the widespread adoption of digital health and imaging technologies creates a solid base for integrating AI into current healthcare systems, enhancing both efficiency and accuracy. Furthermore, ongoing product innovation by major global players, driven by progress in machine learning and growing regulatory backing, is accelerating the availability of AI-based diagnostic solutions. DelveInsight's AI in Diagnostics Market Insights report provides the current and forecast market analysis, individual leading AI in diagnostics companies' market shares, challenges, AI in diagnostics market drivers, barriers, trends, and key market AI in diagnostics companies in the market. Key Takeaways from the AI in Diagnostics Market Report As per DelveInsight estimates, North America is anticipated to dominate the global AI in diagnostics market during the forecast period. In the component segment of the AI in diagnostics market, the software category captured a significant revenue share in 2024. Notable AI in diagnostics companies such as Aidoc, Owkin, Inc., Siemens Healthineers, PathAI, Ibex, Owkin, Inc., Imagen Technologies, Aiforia, RADLogics, Terarecon, Inc., Prenosis, Inc., Ibex, Google LLC, GE HealthCare, DreaMed, Riverain Technologies, Terarecon, Inc., Aiforia, RADLogics, and several others are currently operating in the AI in diagnostics market. In September 2024, Ibex Medical Analytics (Ibex), a leader in AI-powered cancer diagnostics, introduced the latest advancements in its innovative product platform, Ibex-AI. These new features, developed in collaboration with expert pathologists worldwide who actively use the platform in routine clinical practice, highlight Ibex's ongoing commitment to creating cutting-edge diagnostic tools tailored to the needs of healthcare professionals on the frontlines of patient care. In October 2023, Lucida Medical Ltd announced that it received Class IIb CE certification for its AI-powered prostate cancer detection software, Prostate IntelligenceTM (PiTM). Leveraging advanced AI technology, PiTM analyzes MRI scans and is seamlessly integrated into the radiologist's workflow. In March 2023, Qritive launched its latest AI-driven innovation, QAi Prostate, designed specifically for prostate cancer diagnosis. Utilizing cutting-edge machine learning algorithms, QAi Prostate analyzes whole slide images of prostate core needle biopsies with high precision. To read more about the latest highlights related to the AI in diagnostics market, get a snapshot of the key highlights entailed in the Global AI in Diagnostics Market Report AI in Diagnostics Overview Artificial Intelligence (AI) is revolutionizing diagnostics by enabling faster, more accurate detection of diseases through advanced data analysis and pattern recognition. AI-powered systems can analyze medical images such as X-rays, MRIs, and CT scans with high precision, often matching or exceeding the performance of human radiologists in identifying abnormalities like tumors, fractures, or infections. By processing vast amounts of data from electronic health records, lab results, and genomics, AI algorithms can also uncover hidden correlations, assist in early disease prediction, and support personalized treatment plans. Moreover, AI is streamlining workflows in diagnostic laboratories and reducing the burden on healthcare professionals. For instance, AI-driven tools can automate routine tasks such as blood sample analysis or pathology slide interpretation, allowing clinicians to focus on complex cases. In resource-constrained settings, AI has the potential to bridge the gap in healthcare access by providing decision support to less experienced practitioners. As AI continues to evolve, integrating real-time data and improving interpretability, it holds the promise of significantly enhancing diagnostic accuracy, speed, and overall patient in Diagnostics Market Insights North America is expected to dominate the overall Artificial Intelligence (AI) in Diagnostics market over the forecast period, driven by advanced healthcare infrastructure, significant investments in AI technologies, and widespread adoption of digital health solutions. The United States, in particular, leads the region due to its early adoption of cutting-edge technologies, strong presence of leading AI and healthcare companies, and supportive regulatory frameworks. The growing demand for early and accurate diagnosis, especially for chronic and complex diseases such as cancer and cardiovascular conditions, has propelled the integration of AI into diagnostic tools and platforms. Major healthcare institutions in the region are increasingly leveraging AI algorithms for imaging analysis, pathology, and predictive diagnostics, further accelerating market growth. Moreover, robust government initiatives and funding programs supporting AI research in healthcare continue to fuel innovation and development. Strategic collaborations between technology firms and medical institutions are resulting in AI solutions with improved accuracy and efficiency, contributing to enhanced patient outcomes. The presence of a tech-savvy population, favorable reimbursement policies for AI-enabled diagnostic procedures, and a well-established ecosystem of data-driven healthcare systems also contribute to North America's leading position in this domain. As AI technologies mature and gain greater clinical acceptance, the region is expected to remain at the forefront of global advancements in AI-driven diagnostics. To know more about why North America is leading the market growth in the AI in diagnostics market, get a snapshot of the AI in Diagnostics Market Outlook AI in Diagnostics Market Dynamics The AI in diagnostics market has seen significant growth due to technological advancements in machine learning (ML) and artificial intelligence (AI), allowing for the automation and enhancement of diagnostic processes. AI-powered diagnostic tools are revolutionizing areas such as imaging, pathology, and molecular diagnostics, enabling faster, more accurate results with reduced human error. This has become especially crucial in areas like cancer detection, where early identification can significantly impact treatment outcomes. AI algorithms, capable of analyzing vast datasets, can detect patterns and abnormalities in medical imaging that may be missed by the human eye, leading to earlier intervention. The market dynamics are also being influenced by the increasing demand for personalized healthcare. As healthcare systems move towards precision medicine, AI in diagnostics plays a vital role by tailoring diagnostic tests and treatments based on individual genetic profiles. This is particularly significant in oncology, where molecular diagnostics are being enhanced by AI to offer more targeted therapeutic options. With this move toward personalized diagnostics, the role of AI in predicting disease outcomes and treatment responses continues to expand, driving the need for more sophisticated diagnostic tools. Furthermore, regulatory approvals and integration with healthcare systems are key to AI's success in diagnostics. Governments and healthcare bodies are gradually developing guidelines for AI in clinical settings, which is boosting investor confidence and enabling more widespread adoption. However, challenges such as data privacy concerns, interoperability issues, and the need for large-scale validation studies still pose barriers to the full-scale integration of AI diagnostics. As a result, partnerships between AI companies and traditional diagnostic firms are becoming more common to combine the strengths of AI technologies with the reliability and credibility of established healthcare systems. The growing prevalence of chronic diseases and the increasing burden on healthcare systems globally are also driving the adoption of AI in diagnostics. AI can assist in managing large patient populations by streamlining workflows, reducing diagnostic errors, and providing healthcare professionals with better decision-making tools. The market is also seeing the emergence of AI-driven platforms that offer end-to-end diagnostic solutions, from initial patient consultation to final diagnosis, creating a more seamless healthcare experience. As AI technologies continue to mature, the market is expected to experience even greater expansion, making healthcare more accessible, efficient, and accurate. Get a sneak peek at the AI in diagnostics market dynamics @ AI in Diagnostics Market Dynamic Analysis Report Metrics Details Coverage Global Study Period 2022–2032 AI in Diagnostics Market CAGR ~22% AI in Diagnostics Market Size by 2032 USD 8 Billion Key AI in Diagnostics Companies Aidoc, Owkin, Inc., Siemens Healthineers, PathAI, Ibex, Owkin, Inc., Imagen Technologies, Aiforia, RADLogics, Terarecon, Inc., Prenosis, Inc., Ibex, Google LLC, GE HealthCare, DreaMed, Riverain Technologies, Terarecon, Inc., Aiforia, RADLogics, among others AI in Diagnostics Market Assessment AI in Diagnostics Market Segmentation AI in Diagnostics Market Segmentation By Component: Hardware/software, and Services AI in Diagnostics Market Segmentation By Application: Infectious Disease Diagnostics, Radiology, Oncology, Cardiology, and Others AI in Diagnostics Market Segmentation By Technology: Machine Learning, Natural Language Processing, and Others AI in Diagnostics Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View Which MedTech key players in the AI in diagnostics market are set to emerge as the trendsetter explore @ AI in Diagnostics Companies Table of Contents 1 AI in Diagnostics Market Report Introduction 2 AI in Diagnostics Market Executive Summary 3 Competitive Landscape 4 Regulatory Analysis 5 AI in Diagnostics Market Key Factors Analysis 6 AI in Diagnostics Market Porter's Five Forces Analysis 7 AI in Diagnostics Market Layout 8 AI in Diagnostics Market Company and Product Profiles 9 KOL Views 10 Project Approach 11 About DelveInsight 12 Disclaimer & Contact Us Interested in knowing the AI in diagnostics market by 2032? Click to get a snapshot of the AI in Diagnostics Market Trends Related Reports AI in Cancer Diagnostics Market AI in Cancer Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2032 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key AI in cancer diagnostics companies, including iCAD, Inc., ibex-ai, Roche Diagnostics, Kheiron Medical Technologies Limited, MVision AI Inc., Siemens Healthineers AG, GE HealthCare, NVIDIA Corporation, Digital Diagnostics Inc., IBM Corporation, Azra AI, ConcertAI, PathAI, Median Technologies, Paige AI Inc., Therapixel, Flatiron, Freenome Holdings Inc., Sonrai Analytics, among others. Artificial Intelligence In Clinical Trials Market Artificial Intelligence In Clinical Trials Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in clinical trials companies, including TEMPUS, NetraMark, ConcertAI, AiCure, Medpace, Inc., ICON plc, Charles River Laboratories, Dassault Systèmes, Oracle, Certara, Cytel Inc., Phesi, DeepHealth, Inc., H1, TrialX, Suvoda LLC, Risklick, Lokavant, Research Solutions, among others. Artificial Intelligence In Drug Discovery Market Artificial Intelligence In Drug Discovery Market Insights, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of the market trends, market drivers, market barriers, and key AI in drug discovery companies, including IBM Corporation, Numedii Inc, Deep Genomics, NVIDIA Corporation, Atomwise Inc, Cloud Pharmaceuticals Inc, Alphabet Inc (DeepMind), Insilico Medicine, BenevolentAI, Exscientia, Cyclia, Valo Health, Owkin Inc, Verge Genomics, BioSymetrics, among others. Artificial Intelligence in Drug Commercialization Market Artificial Intelligence in Drug Commercialization Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in drug commercialization companies, including EVERSANA, Lyfegen, Syneos Health, McKinsey & Company, ICON plc., Clarivate., Thermo Fisher Scientific Inc., Viseven, ZS Associates, Cloud Pharmaceuticals Inc., among others. Artificial Intelligence in Precision Medicine Market Artificial Intelligence in Precision Medicine Market Insight, Competitive Landscape, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in precision medicine companies, including TEMPUS, GE HealthCare, Envisionit Deep AI (Pty) Ltd., Aignostics, Inc., Proscia Inc., Ultivue, Inc., Prenosis, Inc., IBEX, Cleerly, Inc., Paige AI, Inc., Densitas® Inc., Photocure ASA, iCAD, Inc., Eko Health, Inc., Owkin, Inc, Massive Bio, Deep Bio Inc., Atomwise Inc., among others. About DelveInsight DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. CONTACT: Contact Us Shruti Thakur info@ +14699457679
